Coronary heart disease risk markers in users of low-dose oral contraceptives

• Published in: Journal of reproductive medicine Vol. 36; no. 3 Suppl; p. 226
• Main Authors: Godsland, I F, Crook, D, Wynn, V
• Format: Journal Article
• Language: English
• Published: United States 01.03.1991
• Subjects: Adolescent; Adult; Blood Glucose - metabolism; Cholesterol - blood; Cholesterol, HDL - blood; Cholesterol, LDL - blood; Contraceptives, Oral, Combined - adverse effects; Coronary Disease - chemically induced; Female; Humans; Insulin - blood; Insulin - metabolism; Insulin Secretion; Middle Aged; Risk Factors; Triglycerides - blood; England; Lipids; Biology; Laboratory Procedures; Research Methodology; Heart Diseases; Physiology; Carbohydrate Metabolic Effects > changes; Glucose Tolerance Test; Northern Europe; Laboratory Examinations And Diagnoses; Europe; Oral Contraceptives > side effects; Risk Factors; Oral Contraceptives, Low-dose > side effects; United Kingdom; Contraception; Contraceptive Methods > side effects; Control Groups; Family Planning; Examinations And Diagnoses; Diseases; Developed Countries; Lipid Metabolic Effects > changes; Data Analysis; Metabolic Effects

Seven combination oral contraceptives (OCs) were studied for their effects on glucose, insulin, triglyceride and lipoprotein concentrations. Subjects included 925 women using fixed-dose (monophasic) or variable-dose (triphasic) formulations and 418 premenopausal women not using OCs. The monophasics...